-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VBZwUGpjtBowEH4yRz+g39oSz8CkDNFR4ZTItiqk7vgaUQGU1a1N5fv5v4igNryZ O6sLfuW4oQw4UEcOLaYTxw== 0000950148-96-000184.txt : 19960410 0000950148-96-000184.hdr.sgml : 19960410 ACCESSION NUMBER: 0000950148-96-000184 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960209 SROS: NYSE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DIAGNOSTIC PRODUCTS CORP CENTRAL INDEX KEY: 0000702259 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 952802182 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-34645 FILM NUMBER: 96514140 BUSINESS ADDRESS: STREET 1: 5700 W 96TH ST CITY: LOS ANGELES STATE: CA ZIP: 90045 BUSINESS PHONE: 2137760180 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ZIERING SIGI CENTRAL INDEX KEY: 0001002107 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 5700 W 96TH STREET STREET 2: C/O DIAGNOSTIC PRODUCTS CORP CITY: LOS ANGELES STATE: CA ZIP: 90045 BUSINESS PHONE: 3107760180 MAIL ADDRESS: STREET 1: 5700 W 96TH STREET STREET 2: C/O DIAGNOSTIC PRODUCTS CORP CITY: LOS ANGELES STATE: CA ZIP: 90045 SC 13G/A 1 SC 13G/A 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 11)* DIAGNOSTIC PRODUCTS CORPORATION - ------------------------------------------------------------------------------ (Name of Issuer) COMMON STOCK, NO PAR VALUE - ------------------------------------------------------------------------------ (Title of Class of Securities) 252450-10-1 ----------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [ ]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) *The remainder of this cover page shall be filed out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). PAGE 1 2 CUSIP No. 252450-10-1 13G 1. NAME OF REPORTING PERSON S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON SIGI ZIERING 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP. (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. NUMBER OF 5. SOLE VOTING POWER: 2,462,306 SHARES BENEFICIALLY 6. SHARED VOTING POWER: 49,150 OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER: 2,462,306 PERSON WITH 8. SHARED DISPOSITIVE POWER: 49,150 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,511,456 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 18.57% 12. TYPE OF REPORTING PERSON IN PAGE 2 3 Item 1(a) Name of Issuer: Diagnostic Products Corporation Item 1(b) Address of Issuer's Principal Executive Offices: 5700 West 96th Street Los Angeles, California 90045 Item 2(a) Name of Person Filing: Sigi Ziering Item 2(b) Address of Principal Office: 5700 West 96th Street Los Angeles, CA 90045 Item 2(c) Citizenship: U.S.A. Item 2(d) Title of Class of Securities: Common Stock Item 2(e) CUSIP Number: 252450-10-1 Item 3 Statement filed Pursuant to Rules 13d-1(b) or 13-2(b: Not Applicable Item 4(a) Amount Beneficially Owned: 2,511,456 shares, including 19,150 shares owned by mother who resides in same home (as to which shares beneficial ownership is disclaimed) and 30,000 shares held as trustee of the Diagnostic Products Corporation Profit Sharing Plan as to which beneficial ownership is disclaimed as to all but proportionate interest in such Plan. Item 4(b) Percent of Class: 18.57% Item 4(c) Number of shares as to which reporting person has: (i) sole power to vote or to direct the vote: 2,462,306 (ii) shared power to vote or to direct the vote: 49,150 (iii) sole power to dispose or to direct the disposition of: 2,462,306 (iv) shared power to dispose or to direct the disposition of: 49,150 Item 5 Ownership of 5% or Less of Class: Not Applicable Item 6 Ownership of More than 5% on Behalf of Another Person: Not Applicable Item 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company: Not Applicable Item 8 Identification and Classification of Members of the Group: Not Applicable Item 9 Notice of Dissolution of Group: Not Applicable Item 10 Certification: Not Applicable After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 1, 1996 /S/ Sigi Ziering ------------------------------------------ Sigi Ziering PAGE 3 -----END PRIVACY-ENHANCED MESSAGE-----